Comparison of Two Patient Education Methods in Women With Chronic Low Back Pain: Online Pain Education vs. AI-Driven Patient Education on Pain Beliefs, Catastrophizing, and Self-Efficacy

November 1, 2026 updated by: Aybike Senel, Amasya University

The goal of this study is to learn if ChatGPT-generated answers can improve pain beliefs, catastrophizing, and self-efficacy in women with chronic low back pain compared to supervised pain education. The main questions it aims to answer are: Does ChatGPT improve pain beliefs, catastrophizing, and self-efficacy in women with chronic low back pain? Is ChatGPT as effective as supervised pain education? Participants will: complete baseline questionnaires online, attend a single 30-60 minute online session (randomly assigned to either a supervised pain education presentation or asking frequently questions about low back pain to ChatGPT)

Study Overview

Status

Not yet recruiting

Detailed Description

This study aims to investigate the effects of responses provided by ChatGPT to frequently asked questions about low back pain on pain beliefs, catastrophizing, and self-efficacy in women with chronic low back pain, and to compare them with supervised patient education.

Designed as a randomized controlled trial, this research will be conducted with female participants aged 18-65 with a history of low back pain lasting longer than 3 months will be included. Eligible volunteers will be randomly allocated to either the supervised education group or the ChatGPT group. A single 30-minute session will be conducted with participants in both groups. Participants' pain beliefs will be evaluated using the Pain Beliefs Questionnaire, catastrophizing levels using the Pain Catastrophizing Scale, and self-efficacy levels using the Pain Self-Efficacy Questionnaire. Assessments will be administered twice: immediately before and immediately after the session.

Within the scope of this study, the impact of information obtained from ChatGPT-one of today's widely used and easily accessible AI chatbots-on chronic low back pain, will be revealed. Additionally, comparing these effects with those of supervised pain education may provide a significant contribution to health literacy regarding low back pain.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • To be between 30 and 60 years old
  • To have pain lasting longer than 3 months
  • To have pain intensity greater than 4 out of 10
  • Ability to communicate effectively and understand the study procedures
  • Ability to conduct video calls via Microsoft Teams and complete questionnaires via Google Forms.
  • To be volunteer to participate in the study

Exclusion Criteria:

  • Having previously received pain neuroscience/education or having asked questions regarding pain to ChatGPT or any other chatbots
  • Being pregnant
  • Diagnosis of endocrinological, psychiatric, urogenital, neurological, dermatological, cardiorespiratory, or musculoskeletal diseases, and/or sleep disorders that could interfere with the study outcomes
  • Currently undergoing other treatments for low back pain (e.g., physical therapy, acupuncture).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Patient Education Group

Responses to frequently asked questions about low back pain will be developed within the framework of Pain Neuroscience Education, based on Butler and Moseley's (2003) book "Explain Pain" and current low back pain management guidelines. The prepared responses will be compiled into a PowerPoint presentation and delivered by one of the researchers via screen sharing on Microsoft Teams. The presentation is planned to last approximately 30-60 minutes. All participants in this group will attend the presentation conducted by the same researcher. Participants will not be allowed to ask any additional questions during the session.

Active Comparator: ChatGPT Group

Frequently asked questions about low back pain found in the literature will be sent to participants via email. During screen sharing on Microsoft Teams, participants will be asked to submit these questions one by one to an AI chatbot and carefully read the responses. The same researcher will accompany the participants while they ask all the questions to the AI tool. This process is planned to take approximately 30-60 minutes. Participants will not be allowed to ask any additional questions during the session. However, once all evaluations are completed, a PDF version of the presentation prepared by the researchers will also be shared with participants in this group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Beliefs Questionnaire
Time Frame: baseline

Participants' pain beliefs will be evaluated using the Pain Beliefs Questionnaire. The scale uses a 6-point Likert-type rating ranging from 0 to 5 (never, rarely, sometimes, often, almost always, and always) and consists of 12 items. Two subscale scores are obtained from the questionnaire: psychological pain belief and organic pain belief. A higher score indicates a higher pain belief related to that subscale, whereas a lower score indicates a lower pain belief. The validity and reliability study of the scale has been conducted.

baseline
Pain Catastrophizing Scale
Time Frame: baseline

Participants' level of pain catastrophizing will be evaluated using the Pain Catastrophizing Scale (PCS). The PCS is a 13-item Likert-type self-report scale. Each item is rated on a 0-4 scale. The total score ranges from 0 to 52. It comprises three subscales: rumination, magnification, and helplessness. Higher scores indicate higher levels of catastrophizing. The validity and reliability study of the scale has been conducted.

baseline
Pain Self-Efficacy Questionnaire
Time Frame: baseline

Participants' level of pain-related self-efficacy will be evaluated using the Pain Self-Efficacy Questionnaire (PSEQ). Based on Bandura's concept of self-efficacy, the questionnaire is a 10-item self-report tool designed to measure the degree of confidence in performing a range of activities despite pain. Among questionnaires evaluating pain self-efficacy, it is a practical tool due to its brevity, possesses well-proven validity and reliability, and measures multiple domains of self-efficacy related to social and physical functioning. Each item is rated on a 7-point Likert-type scale (0: Not at all confident, 6: Completely confident). The total score ranges from 0 to 60, with higher scores indicating greater self-efficacy for functionality despite pain. The validity and reliability study of the questionnaire has been conducted.

baseline
Pain Beliefs Questionnaire
Time Frame: immediately after intervention

Participants' pain beliefs will be evaluated using the Pain Beliefs Questionnaire. The scale uses a 6-point Likert-type rating ranging from 0 to 5 (never, rarely, sometimes, often, almost always, and always) and consists of 12 items. Two subscale scores are obtained from the questionnaire: psychological pain belief and organic pain belief. A higher score indicates a higher pain belief related to that subscale, whereas a lower score indicates a lower pain belief. The validity and reliability study of the scale has been conducted.

immediately after intervention
Pain Catastrophizing Scale
Time Frame: immediately after intervention

Participants' level of pain catastrophizing will be evaluated using the Pain Catastrophizing Scale (PCS). The PCS is a 13-item Likert-type self-report scale. Each item is rated on a 0-4 scale. The total score ranges from 0 to 52. It comprises three subscales: rumination, magnification, and helplessness. Higher scores indicate higher levels of catastrophizing. The validity and reliability study of the scale has been conducted.

immediately after intervention
Pain Self-Efficacy Questionnaire
Time Frame: immediately after intervention

Participants' level of pain-related self-efficacy will be evaluated using the Pain Self-Efficacy Questionnaire (PSEQ). Based on Bandura's concept of self-efficacy, the questionnaire is a 10-item self-report tool designed to measure the degree of confidence in performing a range of activities despite pain. Among questionnaires evaluating pain self-efficacy, it is a practical tool due to its brevity, possesses well-proven validity and reliability, and measures multiple domains of self-efficacy related to social and physical functioning. Each item is rated on a 7-point Likert-type scale (0: Not at all confident, 6: Completely confident). The total score ranges from 0 to 60, with higher scores indicating greater self-efficacy for functionality despite pain. The validity and reliability study of the questionnaire has been conducted.

immediately after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2026

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

January 1, 2028

Study Registration Dates

First Submitted

September 20, 2026

First Submitted That Met QC Criteria

November 1, 2026

First Posted (Actual)

November 4, 2026

Study Record Updates

Last Update Posted (Actual)

November 4, 2026

Last Update Submitted That Met QC Criteria

November 1, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe